Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity

Area of Science:

• Rheumatology
• Immunology
• Epidemiology

Background:

• Systemic sclerosis (SSc) is a complex autoimmune disease characterized by fibrosis and vascular abnormalities.
• Inflammatory arthritis (IA) is a recognized, yet not fully understood, manifestation within SSc.
• Understanding the prevalence and impact of IA is crucial for comprehensive SSc patient management.

Purpose of the Study:

• To investigate the epidemiology of inflammatory arthritis (IA) in patients with systemic sclerosis (SSc).
• To identify clinical and serological associations of IA within the SSc cohort.
• To evaluate the impact of IA on physical function and health-related quality of life (HRQoL) in SSc.

Main Methods:

• Prospective enrollment of SSc patients in the Australian Scleroderma Cohort Study.
• Clinical diagnosis of IA based on the presence of synovitis.
• Logistic regression analysis for associations; patient-reported outcome measures for functional impact.

Main Results:

• IA was observed in 33.3% of SSc patients, with a median follow-up of 4.3 years.
• IA associated with diffuse SSc, musculoskeletal issues, myositis, and sicca symptoms; negatively associated with pulmonary arterial hypertension.
• IA linked to lower HRQoL and greater physical disability; anticyclic citrullinated peptide antibodies were more frequent in IA patients.

Conclusions:

• Inflammatory arthritis is a common manifestation in systemic sclerosis, particularly in diffuse disease.
• IA significantly contributes to reduced health-related quality of life and physical disability in SSc patients.
• Further research into effective management strategies for IA in SSc is warranted.